![Fund image](https://cdn.fundingtrip.com/299/Flagship-Ventures-logo.jpg)
Flagship Ventures
Flagship Ventures
Flagship Ventures create breakthroughs in human health and sustainability and build bioplatform companies.
- Use: Go2Market;
- Date closing: -
- Amount: -
- Industry focus: Health; Others;
- Total budget: 3B $
- Entity type: Venture Capital
- Vertical focus: health, sustainability
- Website: https://www.flagshippioneering.com/
- Status: Open
- Funding type:
- Geographic focus:
- Public/Private: Private
- Stage focus: Seed;
- Applicant target: Startup;
Overview
Flagship Ventures are pioneering scientists and professionals who build companies that transform human health and sustainability.
The company announced an expansion of its capital base to support founding and growing its next generation of human health and sustainability companies. Flagship re-opened Fund VII in April 2021 to current Limited Partners and a select group of new investors, raising an additional $2.23 billion for a total capital pool of $3.37 billion. This brings together for the first time its origination and growth strategies under one investment vehicle with a long-term focus on the creation, development, and growth of its first-in-category bioplatform companies.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
Applicants willing to get in touch with Flagship Ventures can do it by following this link.
Portfolio: Axcella, Alltrna, Cellarity, Apriori Bio.
Flagship Ventures FAQ
Flagship Ventures Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Flagship Ventures News
Featured Funds
- Usage: Go2Market;
- Entity type: Venture Capital
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Nordics; Baltics;
- 0 reviews 0 questions
- Usage: Go2Market;
- Entity type: Accelerator
- Funding type: Crowdfunding; Equity investment; In kind; Other;
- Status: Open
- 0 reviews 0 questions
- Usage: Go2Market;
- Entity type: Accelerator
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Global;
- Deadline: February 28, 2022
- 0 reviews 0 questions